To determine the clinical relevance of CD8+ and CD4+ T cell cytotoxicity, we examined the relationship between the cytotoxic populations identified in the single-cell analysis and real-world ICB response in NSCLC. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.